Literature DB >> 33197384

Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.

Nathan Peiffer-Smadja1, Mathieu E Rebeaud2, Anthony Guihur2, Yahya Mahamat-Saleh3, Thibault Fiolet3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33197384      PMCID: PMC7832125          DOI: 10.1016/S1473-3099(20)30866-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
We read with interest the article by Estella Ektorp, which describes the death threats received by Marcus Lacerda following a trial on chloroquine for COVID-19 in Brazil. We give Lacerda our full support and herein report our experience in France and Switzerland following publication of a meta-analysis on hydroxychloroquine, with or without azithromycin, for COVID-19. The meta-analysis included 11 932 participants treated with hydroxychloroquine, 8081 with hydroxychloroquine and azithromycin, and 12 930 patients in a control group. Hydroxychloroquine was not significantly associated with mortality: pooled relative risk (RR) was 0·83 (95% CI 0·65–1·06) across all 17 studies and 1·09 (0·97–1·24) across three randomised controlled trials. Hydroxychloroquine with azithromycin was associated with increased mortality (RR 1·27, 95% CI 1·04–1·54; seven studies). Several authors of this work have suffered a violent campaign of cyber-harassment on social networks, receiving hundreds of insults, xenophobic messages, anonymous phone calls, and intimidation, including death threats. These actions were accompanied by the public sharing of contact details, including the postal address of authors, on Facebook groups with hundreds of thousands of members. In the same way Ektorp describes the response to Lacerda's trial, aggressive communication and an online campaign of misinformation against the meta-analysis were shared by certain medical and scientific professors, as well as French politicians, going beyond the framework of scientific debate and involving the political sphere. This behaviour has a goal: to scare researchers and doctors and to silence them. However, silence would be the worst response to this type of behaviour, making societies vulnerable to populism and obscurantism. In a context of uncertainty and anxiety about the pandemic, and when expectations of clear and accessible medical information were immense, silence left medical communication to the champions of unfounded certainties and outrageous simplifications who were perfectly aware of new forms of communication via social networks and YouTube. Against these communicators, most doctors and researchers were unable to explain either the complexity of the medical process or that doubt, differences, and dialogues between peers are the guarantees of quality medicine. The credibility of medical speech emerges deeply shaken out of this, and the false hopes and disillusions generated by unfounded announcements have undermined confidence in medical research. Citizens are entitled to expect transparent and honest medical information, and we believe this is crucial to address the contemporary challenge of medical communication aimed at the general public, in order to succeed in restoring confidence in medicine and science.
  2 in total

1.  Death threats after a trial on chloroquine for COVID-19.

Authors:  Estella Ektorp
Journal:  Lancet Infect Dis       Date:  2020-06       Impact factor: 25.071

2.  Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.

Authors:  Thibault Fiolet; Anthony Guihur; Mathieu Edouard Rebeaud; Matthieu Mulot; Nathan Peiffer-Smadja; Yahya Mahamat-Saleh
Journal:  Clin Microbiol Infect       Date:  2020-08-26       Impact factor: 8.067

  2 in total
  2 in total

Review 1.  Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis.

Authors:  Jiawen Deng; Fangwen Zhou; Wenteng Hou; Kiyan Heybati; Saif Ali; Oswin Chang; Zachary Silver; Thanansayan Dhivagaran; Harikrishnaa Ba Ramaraju; Chi Yi Wong; Qi Kang Zuo; Elizabeth Lapshina; Madeline Mellett
Journal:  Future Virol       Date:  2022-01-31       Impact factor: 1.831

2.  French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic.

Authors:  Émilien Schultz; Jeremy K Ward; Laëtitia Atlani-Duault; Seth M Holmes; Julien Mancini
Journal:  Int J Environ Res Public Health       Date:  2021-03-05       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.